FDA Investigator Brian L Belz
Brian L Belz has conducted inspections on 2 sites in 2 countries as of 22 Mar 2010. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
22 Mar 2010
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America,
Canada
FDA Investigators that have inspected at least one site in common with Brian L Belz:
Ann L Demarco,
Asamoah Asamoah,
Aurora Miha Trifanov,
Brian R Yaun,
Brooke K Higgins,
Burnell M Henry,
Carrie L Doupnik,
Charisse K Green,
Charles M Edwards,
Dennis L Doupnik,
Djamila Harouaka,
Douglas A Campbell,
Dr. Gang Wang, PhD,
Eileen A Liu,
Emest F Bizjak,
Eric L Dong, BS,
Fabian Nchaparro Rodriguez,
Francis A Guidry,
George Pyramides,
Gifford Whitehurst, Jr,
Hala L Selby,
Jonathan W Chapman,
Katherine Szestypalow,
Kristy A Zielny,
Kristy E Zuroski,
Laurimer Kuilan Torres,
Lawrence Harmon, Jr,
LCDR Debra Emerson,
Lloyd D Payne,
Marcus A Ray,
Marian E Ramirez,
Matthew C Watson,
Melissa J Garcia,
Michael R Goga,
Monica E Caphart,
Parul M Patel,
Qin Xu,
S Lori Brown, PhD MPH,
Sam Pepe,
Sarah E Mcmullen,
Simone E Pitts,
Steven M Weinman,
Susan M Jackson,
Susanne M Richardson, MS RAC,
Thomas R Withers,
Toyin B Oladimeji,
Truong Xuan Nguyen (Andy),
Vesna V Stanoyevitch,
Walden H Lee,
Zhongren Wu
Brian L Belz's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2010 | FDA 483 | Barr Laboratories Inc. - Form 483, 2010-04-08 |
August, 2009 | EIR | Apotex Inc. - EIR, 2009-08-14 |
August, 2009 | FDA 483 | Apotex Inc. - Form 483, 2009-08-14 |
August, 2009 | FDA 483 Response | Apotex Inc. - Form 483R, 2009-09-03 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more